Cipla Ltd.

BSE: 500087 | NSE: CIPLA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE059A01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Cipla Ltd. Cipla Ltd. | BSE 1466.15 5.55 (0.38%) | NSE 1465.70 5.10 (0.35%) | Trade | Add

BSE Live

Jan 09, 16:01

1466.15 5.55 (0.38%)

Volume

AVERAGE VOLUME

5-Day

250,274

10-Day

139,788

30-Day

110,890

251,355

Prev. Close

1460.60
Open Price

1464.95

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 09, 15:58

1465.70 5.10 (0.35%)

Volume

AVERAGE VOLUME

5-Day

2,367,783

10-Day

1,697,346

30-Day

1,233,425

1,804,271

Prev. Close

1460.60
Open Price

1464.70

Bid Price (Qty.)
1465.70 (70)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Cipla (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	11,059.79	9,916.56	8,226.95	6,985.16	6,187.13
Less: Excise/Sevice Tax/Other Levies	109.03	117.14	108.69	108.11	68.44
Revenue From Operations [Net]	10,950.76	9,799.42	8,118.26	6,877.05	6,118.69
Total Operating Revenues	11,345.44	10,100.39	8,279.33	7,020.71	6,323.84
Other Income	165.55	265.37	222.14	139.52	91.68
Total Revenue	11,510.99	10,365.76	8,501.47	7,160.23	6,415.52
EXPENSES
Cost Of Materials Consumed	3,740.24	3,376.22	2,728.92	2,326.35	2,384.07
Purchase Of Stock-In Trade	793.68	562.86	514.30	407.30	529.98
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-344.22	-64.25	-290.60	5.65	-138.87
Employee Benefit Expenses	1,973.67	1,542.96	1,036.26	772.52	565.59
Finance Costs	168.29	145.74	33.91	38.34	25.10
Depreciation And Amortisation Expenses	504.71	372.64	330.48	312.22	273.33
Other Expenses	3,020.37	2,549.55	2,092.60	1,850.04	1,613.83
Total Expenses	9,856.74	8,485.72	6,445.87	5,712.42	5,253.03
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1,654.25	1,880.04	2,055.60	1,447.81	1,162.49
Exceptional Items	0.00	0.00	39.77	0.00	0.00
Profit/Loss Before Tax	1,654.25	1,880.04	2,095.37	1,447.81	1,162.49
Tax Expenses-Continued Operations
Current Tax	403.61	436.96	427.25	286.39	232.01
Less: MAT Credit Entitlement	0.00	0.00	-70.00	0.00	70.00
Deferred Tax	-3.71	26.42	47.29	20.12	33.21
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	400.03	463.38	544.31	306.51	195.36
Profit/Loss After Tax And Before ExtraOrdinary Items	1,254.22	1,416.66	1,551.06	1,141.30	967.13
Profit/Loss From Continuing Operations	1,254.22	1,416.66	1,551.06	1,141.30	967.13
Profit/Loss For The Period	1,254.22	1,416.66	1,551.06	1,141.30	967.13
Minority Interest	-48.15	-15.93	0.00	0.00	0.00
Consolidated Profit/Loss After MI And Associates	1,180.77	1,388.41	1,544.85	1,144.24	989.57
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	15.00	17.00	19.00	14.00	12.00
Diluted EPS (Rs.)	15.00	17.00	19.00	14.00	12.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	160.59	160.58	160.58	160.58	224.81
Tax On Dividend	32.69	27.29	27.29	26.05	36.72